Question 1

What is MIRIKIZUMAB-MRKZ used for?

Accepted Answer

MIRIKIZUMAB-MRKZ (brand name Omvoh) is a Other indicated for See full prescribing information.

Question 2

How does MIRIKIZUMAB-MRKZ work?

Accepted Answer

MIRIKIZUMAB-MRKZ works through the following mechanism: 12.1 Mechanism of Action Mirikizumab-mrkz is a humanized IgG4 monoclonal antibody that selectively binds to the p19 subunit of human IL-23 cytokine and inhibits its interaction with the IL-23 receptor. IL-23 is involved in mucosal inflammation and affects the differentiation, expansion, and survival of T cell subsets, and innate immune cell subsets, which represent sources of pro-inflammatory cytokines. Research in animal models has shown that pharmacologic inhibition of IL-23p19 can ameliorate intestinal inflammation. Mirikizumab-mrkz inhibits the release of pro-inflammatory cytokines and chemokines..

Question 3

What are the most common side effects of MIRIKIZUMAB-MRKZ?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for MIRIKIZUMAB-MRKZ. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is MIRIKIZUMAB-MRKZ the same as Omvoh?

Accepted Answer

Omvoh is a brand name for MIRIKIZUMAB-MRKZ. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

MIRIKIZUMAB-MRKZ

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations